GSK plc ( GSK) - Stock Earnings
GSK Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 2.0 billion USD | 8.5 billion USD |
| 2025Q4 | 636.0 million USD | 8.6 billion USD |
| 2026Q1 | 1.7 billion USD | 7.6 billion USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GSK Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 4.9 billion USD | 30.3 billion USD |
| 2024 | 2.6 billion USD | 31.4 billion USD |
| 2025 | 5.7 billion USD | 32.7 billion USD |
| 2026 Est. | — | — |
GSK
Price: $51.27
Dividend Yield: 3.62%
Forward Dividend Yield: 3.43%
Payout Ratio: 52.47%
Dividend Per Share: 1.76 USD
Earnings Per Share: 3.86 USD
P/E Ratio: 13.05
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Volume: 3.7 million
Ebitda: 2.0 billionMarket Capitalization: 100.0 billion
Average Dividend Frequency: 4
Years Paying Dividends: 43
DGR3: 0.42%
DGR5: 0.12%
DGR10: -2.10%
DGR20: 1.63%